However, studies on hSOD1 p.G93A transgenic model of ALS in vivo generally show no effect of the mutation on BiP expression or decrease in chaperone levels in spinal cord neurons in case of early onset or progression of ALS-like symptoms (Figure 3). Here, HSPA5 is linked to amyotrophic lateral sclerosis.